Tokyo, Aug. 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058721) titled '"Incidence and Characteristics of Hypocalcemia after initiation or switching of calcimimetics"' on Aug. 8.
Study Type:
Observational
Primary Sponsor:
Institute - Patient Driven Academic League
Condition:
Condition - Japanese Dialysis Patients with CKD-MBD
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to compare the incidence of hypocalcemia among different calcimimetic formulations in dialysis patients with CKD-MBD. Additionally, we will describe the therapeutic interventions implemented following hypocalcemia and the subsequent course of recovery.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Hemodialysis patients attending a dialysis facility as outpatients who agree to participate in the study
Key exclusion criteria - Patients on peritoneal dialysis
Target Size - 8800
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2018 Year 03 Month 26 Day
Date of IRB - 2018 Year 03 Month 26 Day
Anticipated trial start date - 2018 Year 04 Month 01 Day
Last follow-up date - 2024 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067133
Disclaimer: Curated by HT Syndication.
